Dmi Biosciences

Ampio Pharmaceuticals dissolved as of August 16, 2024, following stockholder approval of the Plan of Dissolution on August 15, 2024. The company intends to distribute any remaining cash to stockholders after settling legal obligations, subject to Delaware Chancery Court approval. Updates will be posted on the website, and stockholders should direct inquiries about their holdings to their broker or Equiniti, Ampio’s transfer agent.

Michael A. Martino served as Chief Executive Officer. The company's website indicates that it is addressing the final stages of dissolution and asset distribution.